De novo belatacept does not reduce the rate of skin cancer in renal transplant recipients compared to standard therapy.
作者信息
Jew Olivia S, Liu Winston W, Stamey Christopher, Kheterpal Meenal, Myers Sarah A, Ellis Matthew J, Byrns Jennifer, Wheless Lee, Whitley Melodi Javid
机构信息
Department of Dermatology, Duke University Health System, Durham, North Carolina.
Duke University School of Medicine, Durham, North Carolina.
出版信息
J Am Acad Dermatol. 2024 Oct;91(4):720-722. doi: 10.1016/j.jaad.2024.05.068. Epub 2024 Jun 4.
Abstract
摘要
相似文献
1
De novo belatacept does not reduce the rate of skin cancer in renal transplant recipients compared to standard therapy.
J Am Acad Dermatol. 2024 Oct;91(4):720-722. doi: 10.1016/j.jaad.2024.05.068. Epub 2024 Jun 4.
2
Belatacept reduces skin cancer risk in kidney transplant recipients.
J Am Acad Dermatol. 2020 Apr;82(4):996-998. doi: 10.1016/j.jaad.2019.09.070. Epub 2019 Oct 4.
3
Long-Term Outcomes after Conversion to a Belatacept-Based Immunosuppression in Kidney Transplant Recipients.
Clin J Am Soc Nephrol. 2024 May 1;19(5):628-637. doi: 10.2215/CJN.0000000000000411. Epub 2024 Feb 22.
4
Microvascular inflammation is a risk factor in kidney transplant recipients with very late conversion from calcineurin inhibitor-based regimens to belatacept.
BMC Nephrol. 2020 Aug 20;21(1):354. doi: 10.1186/s12882-020-01992-6.
5
Belatacept Versus Tacrolimus for Kidney Transplant Recipients of Deceased Donors With Acute Kidney Injury: US National Database Study.
Transplantation. 2025 Apr 1;109(4):691-700. doi: 10.1097/TP.0000000000005196. Epub 2024 Sep 4.
6
Temporal trends and current use of de novo belatacept in kidney transplant recipients in the United States.
Clin Transplant. 2022 Mar;36(3):e14531. doi: 10.1111/ctr.14531. Epub 2021 Nov 29.
7
Belatacept prophylaxis against organ rejection in adult kidney-transplant recipients.
Expert Rev Clin Pharmacol. 2016;9(2):215-27. doi: 10.1586/17512433.2016.1112736. Epub 2015 Dec 22.
8
Safety and Efficacy Outcomes 3 Years After Switching to Belatacept From a Calcineurin Inhibitor in Kidney Transplant Recipients: Results From a Phase 2 Randomized Trial.
Am J Kidney Dis. 2017 May;69(5):587-594. doi: 10.1053/j.ajkd.2016.09.021. Epub 2016 Nov 23.
9
Abatacept as rescue immunosuppression after calcineurin inhibitor treatment failure in renal transplantation.
Am J Transplant. 2019 Aug;19(8):2342-2349. doi: 10.1111/ajt.15319. Epub 2019 Mar 12.
10
Belatacept for kidney transplant recipients.
Cochrane Database Syst Rev. 2014 Nov 24;2014(11):CD010699. doi: 10.1002/14651858.CD010699.pub2.
引用本文的文献
1
Belatacept and non-melanoma skin cancer risk in kidney transplant recipients: a narrative review from a mechanistic and clinical perspective.
BMC Nephrol. 2025 Aug 23;26(1):487. doi: 10.1186/s12882-025-04373-z.
2
Immunosuppressants/Immunomodulators and Malignancy.
J Clin Med. 2025 Jul 21;14(14):5160. doi: 10.3390/jcm14145160.
3
Cancer Screening and Cancer Treatment in Kidney Transplant Recipients.
Kidney360. 2024 Oct 1;5(10):1569-1583. doi: 10.34067/KID.0000000000000545.
4
Cutaneous Squamous Cell Carcinoma in Patients with Solid-Organ-Transplant-Associated Immunosuppression.
Cancers (Basel). 2024 Sep 4;16(17):3083. doi: 10.3390/cancers16173083.
本文引用的文献
1
Costimulatory Blockade and Solid Organ Transplantation: The Past, Present, and Future.
Kidney Int Rep. 2023 Sep 3;8(12):2529-2545. doi: 10.1016/j.ekir.2023.08.037. eCollection 2023 Dec.
2
Differences in Skin Cancer Rates by Transplanted Organ Type and Patient Age After Organ Transplant in White Patients.
JAMA Dermatol. 2022 Nov 1;158(11):1287-1292. doi: 10.1001/jamadermatol.2022.3878.
3
Cohort and nested case-control study of cutaneous squamous cell carcinoma in solid organ transplant recipients, by medication.
J Am Acad Dermatol. 2022 Mar;86(3):598-606. doi: 10.1016/j.jaad.2021.07.065. Epub 2021 Aug 9.
4
Belatacept reduces skin cancer risk in kidney transplant recipients.
J Am Acad Dermatol. 2020 Apr;82(4):996-998. doi: 10.1016/j.jaad.2019.09.070. Epub 2019 Oct 4.
5
Predicting skin cancer in organ transplant recipients: development of the SUNTRAC screening tool using data from a multicenter cohort study.
Transpl Int. 2019 Dec;32(12):1259-1267. doi: 10.1111/tri.13493. Epub 2019 Oct 7.
Zotero 插件